Oncogene - Table of Contents alert Volume 31 Issue 4

TABLE OF CONTENTS Volume 31, Issue 4 (January 2012) In this issue Original Articles Short Communication Corrigendum Also new AOP Advertisement Complimentary PI3 Kinase Pathway Poster Rockland antibodies and assays for Cancer, Cell Biology, Cell Signaling and Neuroscience research are guaranteed to give predictable, repeatable results. Protect your experiments with Rockland antibodies. Compromise elsewhere. Click here to register for a free PI3 Kinase Pathway Poster and visit our redesigned, content-rich website at www.rockland-inc.com Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement Continuing a tradition of excellence Oncogene, now in its 24th year of publication, continues to present the most essential developments in cancer research. Visit Oncogene's website now!   Original Articles Top CHEK2 genomic and proteomic analyses reveal genetic inactivation or endogenous activation across the 60 cell lines of the US National Cancer Institute G Zoppoli, S Solier, W C Reinhold, H Liu, J W Connelly, Jr, A Monks, R H Shoemaker, O D Abaan, S R Davis, P S Meltzer, J H Doroshow and Y Pommier Oncogene 2012 31: 403-418; advance online publication, July 18, 2011; 10.1038/onc.2011.283 Abstract | Full Text A tumor-suppressing function in the epithelial adhesion protein Trask D S Spassov, C H Wong, G Harris, S McDonough, P Phojanakong, D Wang, B Hann, A V Bazarov, P Yaswen, E Khanafshar and M M Moasser Oncogene 2012 31: 419-431; advance online publication, June 27, 2011; 10.1038/onc.2011.246 Abstract | Full Text MiR-200b and miR-15b regulate chemotherapy-induced epithelial-mesenchymal transition in human tongue cancer cells by targeting BMI1 L Sun, Y Yao, B Liu, Z Lin, L Lin, M Yang, W Zhang, W Chen, C Pan, Q Liu, E Song and J Li Oncogene 2012 31: 432-445; advance online publication, July 4, 2011; 10.1038/onc.2011.263 Abstract | Full Text Concurrent loss of the PTEN and RB1 tumor suppressors attenuates RAF dependence in melanomas harboring V600EBRAF F Xing, Y Persaud, C A Pratilas, B S Taylor, M Janakiraman, Q-B She, H Gallardo, C Liu, T Merghoub, B Hefter, I Dolgalev, A Viale, A Heguy, E De Stanchina, D Cobrinik, G Bollag, J Wolchok, A Houghton and D B Solit Oncogene 2012 31: 446-457; advance online publication, July 4, 2011; 10.1038/onc.2011.250 Abstract | Full Text MMP-9 from sublethally irradiated tumor promotes Lewis lung carcinoma cell invasiveness and pulmonary metastasis C H Chou, C-M Teng, K-Y Tzen, Y-C Chang, J-H Chen and J C-H Cheng Oncogene 2012 31: 458-468; advance online publication, June 27, 2011; 10.1038/onc.2011.240 Abstract | Full Text Altered LKB1/CREB-regulated transcription co-activator (CRTC) signaling axis promotes esophageal cancer cell migration and invasion Y Gu, S Lin, J-L Li, H Nakagawa, Z Chen, B Jin, L Tian, D A Ucar, H Shen, J Lu, S N Hochwald, F J Kaye and L Wu Oncogene 2012 31: 469-479; advance online publication, June 27, 2011; 10.1038/onc.2011.247 Abstract | Full Text MT1-MMP protects breast carcinoma cells against type I collagen-induced apoptosis E Maquoi, D Assent, J Detilleux, C Pequeux, J-M Foidart and A Noël Oncogene 2012 31: 480-493; advance online publication, June 27, 2011; 10.1038/onc.2011.249 Abstract | Full Text The clathrin-binding domain of CALM-AF10 alters the phenotype of myeloid neoplasms in mice A Stoddart, T R Tennant, A A Fernald, J Anastasi, F M Brodsky and M M Le Beau Oncogene 2012 31: 494-506; advance online publication, June 27, 2011; 10.1038/onc.2011.251 Abstract | Full Text Methylation-mediated repression of microRNA-143 enhances MLL–AF4 oncogene expression L Dou, D Zheng, J Li, Y Li, L Gao, L Wang and L Yu Oncogene 2012 31: 507-517; advance online publication, June 27, 2011; 10.1038/onc.2011.248 Abstract | Full Text The effect Akt2 deletion on tumor development in Pten+/− mice P-Z Xu, M-L Chen, S-M Jeon, X-d Peng and N Hay Oncogene 2012 31: 518-526; advance online publication, July 11, 2011; 10.1038/onc.2011.243 Abstract | Full Text Short Communication Top RUNX3 acts as a tumor suppressor in breast cancer by targeting estrogen receptor α B Huang, Z Qu, C W Ong, Y-H N Tsang, G Xiao, D Shapiro, M Salto-Tellez, K Ito, Y Ito and L-F Chen Oncogene 2012 31: 527-534; advance online publication, June 27, 2011; 10.1038/onc.2011.252 Abstract | Full Text Corrigendum Top CHEK2 genomic and proteomic analyses reveal genetic inactivation or endogenous activation across the 60 cell lines of the US National Cancer Institute G Zoppoli, S Solier, W C Reinhold, H Liu, J W Connelly, Jr, A Monks, R H Shoemaker, O D Abaan, S R Davis, P S Meltzer, J H Doroshow and Y Pommier Oncogene 2012 31: 535-536; 10.1038/onc.2011.420 Full Text Advertisement Call for papers! Submit your best work in cancer research, including mechanisms of cellular oncogene activation, structure and function of encoded proteins, DNA and RNA tumor viruses and all other aspects of oncogene structure and function. Our online submission process is easy and can assist you in becoming part of this distinguished journal. Visit our Author page to learn about the benefits of publishing in the Journal and for guidelines on how to submit your paper.   Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2012 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.